Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alemtuzumab; Fludarabine; Melphalan
- Indications Graft-versus-host disease; Histiocytosis
- Focus Therapeutic Use
Most Recent Events
- 28 Dec 2017 Biomarkers information updated
- 11 Jun 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Apr 2010 Additional trial identifiers (LCH-HCT2006) identified as reported by ClinicalTrials.gov.